Detalhe da pesquisa
1.
Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon.
Cochrane Database Syst Rev
; 11: CD014089, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929840
2.
Pharmacokinetics of aminocaproic acid in thoroughbred horses.
J Vet Pharmacol Ther
; 46(4): 250-256, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994984
3.
Tramadol for osteoarthritis.
Cochrane Database Syst Rev
; 5: CD005522, 2019 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132298
4.
Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Cochrane Database Syst Rev
; 12: CD000467, 2017 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29237099
5.
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Cochrane Database Syst Rev
; 5: CD012657, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481462
6.
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
Cochrane Database Syst Rev
; 3: CD012591, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28282491
7.
Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats.
Clin Exp Pharmacol Physiol
; 44(8): 872-879, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440910
8.
Antiherpetic Drugs in Equine Medicine.
Vet Clin North Am Equine Pract
; 33(1): 99-125, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28325183
9.
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
Cochrane Database Syst Rev
; (5): CD012183, 2016 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27175934
10.
Chondroitin for osteoarthritis.
Cochrane Database Syst Rev
; 1: CD005614, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629804
11.
TNF-alpha inhibitors for ankylosing spondylitis.
Cochrane Database Syst Rev
; (4): CD005468, 2015 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887212
12.
Diacerein for osteoarthritis.
Cochrane Database Syst Rev
; (2): CD005117, 2014 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24515444
13.
Stability of 1% voriconazole solution in a constant-rate infusion pump for topical ocular delivery to horses.
Vet Ophthalmol
; 17 Suppl 1: 82-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602272
14.
Pharmacokinetics of amikacin after intravenous, intra-articular, and combined intravenous and intra-articular administration in healthy neonatal foals.
J Vet Intern Med
; 38(3): 1825-1834, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647141
15.
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group.
Semin Arthritis Rheum
; 64: 152340, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071831
16.
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.
Semin Arthritis Rheum
; 66: 152422, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461757
17.
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023.
Semin Arthritis Rheum
; 66: 152438, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555726
18.
Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop.
Semin Arthritis Rheum
; 64: 152342, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128175
19.
Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
Semin Arthritis Rheum
; 64: 152338, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134623
20.
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.
Semin Arthritis Rheum
; 66: 152423, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460282